The deep brain stimulation systems market size has grown rapidly in recent years. It will grow from $2.77 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to growing prevalence of neurological disorders, increasing clinical acceptance of neuromodulation therapies, advancements in implantable medical device technology, expansion of neurology specialty centers, improved long-term patient outcomes.
The deep brain stimulation systems market size is expected to see rapid growth in the next few years. It will grow to $4.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing investments in next-generation neurostimulation devices, rising demand for personalized neurological treatments, expansion of dbs indications beyond movement disorders, growing integration of ai-driven programming, increasing focus on remote patient monitoring. Major trends in the forecast period include increasing adoption of adaptive dbs systems, rising use of image-guided electrode placement, growing demand for rechargeable neurostimulators, expansion of personalized neuromodulation therapies, enhanced focus on minimally invasive implantation techniques.
The rising prevalence of neurological disorders is expected to drive the growth of the deep brain stimulation systems market in the coming years. Neurological disorders encompass a diverse group of diseases that affect the body’s autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are utilized in neurosurgical procedures to deliver electrical impulses to targeted brain regions, with the goal of modifying or regulating neural activity and achieving a reversible, adjustable, and therapeutic outcome. For example, in October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, more than 40% of the global population is currently affected by some form of neurological condition, and this burden is projected to nearly double by 2050. Consequently, the increasing prevalence of neurological disorders is contributing to the growth of the deep brain stimulation systems market.
Key players within the deep brain stimulation systems market are actively engaged in pioneering innovative technologies, such as deep brain stimulation (DBS) systems, to cater to patients with movement disorders. DBS entails a medical procedure involving the implantation of a device that administers electrical currents directly to specific brain regions. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and healthcare company, unveiled the Liberta RC DBS system - a groundbreaking rechargeable deep brain stimulation device with remote programming capabilities, deemed the world's smallest in its category. The Liberta RC DBS system represents a pioneering advancement in connected care technology, allowing patients to maintain communication with their healthcare providers, ensure optimal device configuration and operation, and receive updated treatment settings remotely as needed, eliminating the necessity for in-person visits to medical facilities.
In October 2025, Medtronic plc, a US-based medical device company offering a comprehensive range of deep brain stimulation (DBS) technologies and technical support, entered into a partnership with Siemens Healthineers for an undisclosed amount. This collaboration is intended to integrate advanced imaging capabilities into Medtronic’s AiBLE ecosystem, which includes surgical navigation and robotic platforms, thereby improving the accuracy of electrode placement in neurosurgical procedures, including DBS used to treat movement disorders such as Parkinson’s disease. Siemens Healthineers is a Germany-based medical technology company.
Major companies operating in the deep brain stimulation systems market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Beijing PINS Medical Co Ltd, SceneRay Corporation Ltd, NeuroPace Inc, LivaNova PLC, NeuroSigma Inc, Functional Neuromodulation Ltd, Synapse Biomedical Inc, Soterix Medical Inc, FHC Inc, Newronika S.p.A, Renishaw plc, Deep Brain Innovations LLC, BlueWind Medical Ltd, Magstim Company Ltd, Sapiens Steering Brain Stimulation, Bioinduction Ltd, Alpha Omega Engineering.
North America was the largest region in the deep brain stimulation systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the deep brain stimulation systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the deep brain stimulation systems market by increasing costs of imported microelectronics, implantable electrodes, pulse generators, and precision manufacturing components. Hospitals and neurological centers in North America and Europe are most affected due to reliance on globally sourced medical device components, while Asia-Pacific faces pricing pressure on device imports. These tariffs are contributing to higher procedural costs and extended procurement cycles. However, they are also encouraging localized manufacturing, regional supply chain diversification, and investment in domestic production of advanced neuromodulation systems.
The deep brain stimulation systems market research report is one of a series of new reports that provides deep brain stimulation systems market statistics, including deep brain stimulation systems industry global market size, regional shares, competitors with a deep brain stimulation systems market share, detailed deep brain stimulation systems market segments, market trends and opportunities, and any further data you may need to thrive in the deep brain stimulation systems industry. This deep brain stimulation systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A deep brain stimulation (DBS) system is a medical device that employs implanted electrodes to deliver controlled electrical pulses to specific areas of the brain. This technology is utilized to regulate abnormal brain activity and alleviate symptoms associated with various neurological conditions.
The primary products within the realm of deep brain stimulation systems are single-channel and dual-channel systems. Single-channel systems involve devices designed for applying targeted electrical or magnetic stimulation to specific brain regions. These systems find applications across various medical conditions, including Parkinson's disease, essential tremor, obsessive-compulsive disorder, epilepsy, dystonia, and others. These systems are employed by diverse end-users such as hospitals, ambulatory surgical centers, neurological clinics, and other healthcare facilities.
The deep brain stimulation system market includes revenues earned by entities by providing services such as electrode implantation, pulse generator implantation, surgical implantation services, diagnostic and preoperative services, programming and adjustment services, patient education and support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The deep brain stimulation system market also includes of sales of extension wires, remote controls, and electrodes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The deep brain stimulation systems market size is expected to see rapid growth in the next few years. It will grow to $4.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing investments in next-generation neurostimulation devices, rising demand for personalized neurological treatments, expansion of dbs indications beyond movement disorders, growing integration of ai-driven programming, increasing focus on remote patient monitoring. Major trends in the forecast period include increasing adoption of adaptive dbs systems, rising use of image-guided electrode placement, growing demand for rechargeable neurostimulators, expansion of personalized neuromodulation therapies, enhanced focus on minimally invasive implantation techniques.
The rising prevalence of neurological disorders is expected to drive the growth of the deep brain stimulation systems market in the coming years. Neurological disorders encompass a diverse group of diseases that affect the body’s autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are utilized in neurosurgical procedures to deliver electrical impulses to targeted brain regions, with the goal of modifying or regulating neural activity and achieving a reversible, adjustable, and therapeutic outcome. For example, in October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, more than 40% of the global population is currently affected by some form of neurological condition, and this burden is projected to nearly double by 2050. Consequently, the increasing prevalence of neurological disorders is contributing to the growth of the deep brain stimulation systems market.
Key players within the deep brain stimulation systems market are actively engaged in pioneering innovative technologies, such as deep brain stimulation (DBS) systems, to cater to patients with movement disorders. DBS entails a medical procedure involving the implantation of a device that administers electrical currents directly to specific brain regions. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and healthcare company, unveiled the Liberta RC DBS system - a groundbreaking rechargeable deep brain stimulation device with remote programming capabilities, deemed the world's smallest in its category. The Liberta RC DBS system represents a pioneering advancement in connected care technology, allowing patients to maintain communication with their healthcare providers, ensure optimal device configuration and operation, and receive updated treatment settings remotely as needed, eliminating the necessity for in-person visits to medical facilities.
In October 2025, Medtronic plc, a US-based medical device company offering a comprehensive range of deep brain stimulation (DBS) technologies and technical support, entered into a partnership with Siemens Healthineers for an undisclosed amount. This collaboration is intended to integrate advanced imaging capabilities into Medtronic’s AiBLE ecosystem, which includes surgical navigation and robotic platforms, thereby improving the accuracy of electrode placement in neurosurgical procedures, including DBS used to treat movement disorders such as Parkinson’s disease. Siemens Healthineers is a Germany-based medical technology company.
Major companies operating in the deep brain stimulation systems market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Beijing PINS Medical Co Ltd, SceneRay Corporation Ltd, NeuroPace Inc, LivaNova PLC, NeuroSigma Inc, Functional Neuromodulation Ltd, Synapse Biomedical Inc, Soterix Medical Inc, FHC Inc, Newronika S.p.A, Renishaw plc, Deep Brain Innovations LLC, BlueWind Medical Ltd, Magstim Company Ltd, Sapiens Steering Brain Stimulation, Bioinduction Ltd, Alpha Omega Engineering.
North America was the largest region in the deep brain stimulation systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the deep brain stimulation systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the deep brain stimulation systems market by increasing costs of imported microelectronics, implantable electrodes, pulse generators, and precision manufacturing components. Hospitals and neurological centers in North America and Europe are most affected due to reliance on globally sourced medical device components, while Asia-Pacific faces pricing pressure on device imports. These tariffs are contributing to higher procedural costs and extended procurement cycles. However, they are also encouraging localized manufacturing, regional supply chain diversification, and investment in domestic production of advanced neuromodulation systems.
The deep brain stimulation systems market research report is one of a series of new reports that provides deep brain stimulation systems market statistics, including deep brain stimulation systems industry global market size, regional shares, competitors with a deep brain stimulation systems market share, detailed deep brain stimulation systems market segments, market trends and opportunities, and any further data you may need to thrive in the deep brain stimulation systems industry. This deep brain stimulation systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A deep brain stimulation (DBS) system is a medical device that employs implanted electrodes to deliver controlled electrical pulses to specific areas of the brain. This technology is utilized to regulate abnormal brain activity and alleviate symptoms associated with various neurological conditions.
The primary products within the realm of deep brain stimulation systems are single-channel and dual-channel systems. Single-channel systems involve devices designed for applying targeted electrical or magnetic stimulation to specific brain regions. These systems find applications across various medical conditions, including Parkinson's disease, essential tremor, obsessive-compulsive disorder, epilepsy, dystonia, and others. These systems are employed by diverse end-users such as hospitals, ambulatory surgical centers, neurological clinics, and other healthcare facilities.
The deep brain stimulation system market includes revenues earned by entities by providing services such as electrode implantation, pulse generator implantation, surgical implantation services, diagnostic and preoperative services, programming and adjustment services, patient education and support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The deep brain stimulation system market also includes of sales of extension wires, remote controls, and electrodes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Deep Brain Stimulation Systems Market Characteristics
3. Deep Brain Stimulation Systems Market Supply Chain Analysis
4. Global Deep Brain Stimulation Systems Market Trends and Strategies
5. Deep Brain Stimulation Systems Market Analysis of End Use Industries
7. Global Deep Brain Stimulation Systems Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Deep Brain Stimulation Systems Total Addressable Market (TAM) Analysis for the Market
9. Deep Brain Stimulation Systems Market Segmentation
10. Deep Brain Stimulation Systems Market Regional and Country Analysis
11. Asia-Pacific Deep Brain Stimulation Systems Market
12. China Deep Brain Stimulation Systems Market
13. India Deep Brain Stimulation Systems Market
14. Japan Deep Brain Stimulation Systems Market
15. Australia Deep Brain Stimulation Systems Market
16. Indonesia Deep Brain Stimulation Systems Market
17. South Korea Deep Brain Stimulation Systems Market
18. Taiwan Deep Brain Stimulation Systems Market
19. South East Asia Deep Brain Stimulation Systems Market
20. Western Europe Deep Brain Stimulation Systems Market
21. UK Deep Brain Stimulation Systems Market
22. Germany Deep Brain Stimulation Systems Market
23. France Deep Brain Stimulation Systems Market
24. Italy Deep Brain Stimulation Systems Market
25. Spain Deep Brain Stimulation Systems Market
26. Eastern Europe Deep Brain Stimulation Systems Market
27. Russia Deep Brain Stimulation Systems Market
28. North America Deep Brain Stimulation Systems Market
29. USA Deep Brain Stimulation Systems Market
30. Canada Deep Brain Stimulation Systems Market
31. South America Deep Brain Stimulation Systems Market
32. Brazil Deep Brain Stimulation Systems Market
33. Middle East Deep Brain Stimulation Systems Market
34. Africa Deep Brain Stimulation Systems Market
36. Deep Brain Stimulation Systems Market Competitive Landscape and Company Profiles
37. Deep Brain Stimulation Systems Market Other Major and Innovative Companies
40. Deep Brain Stimulation Systems Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Deep Brain Stimulation Systems Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses deep brain stimulation systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for deep brain stimulation systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deep brain stimulation systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Single Channel; Dual Channel2) By Application: Parkinson's Disease; Essential Tremor; Obsessive Compulsive Disorder; Epilepsy; Dystonia; Other Applications
3) By End-user: Hospitals; Ambulatory Surgical Centers; Neurological Clinics; Other End Users
Subsegments:
1) By Single Channel: Unilateral Deep Brain Stimulation (DBS) Systems; Single Lead Deep Brain Stimulation (DBS) Systems; Targeted Single Nucleus DBS Systems; Standard Single Channel Neurostimulation Systems2) By Dual Channel: Bilateral Deep Brain Stimulation (DBS) Systems; Dual Lead Deep Brain Stimulation (DBS) Systems; Multi-Nucleus Targeted DBS Systems; Advanced Dual Channel Neurostimulation Systems
Companies Mentioned: Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Aleva Neurotherapeutics SA; Beijing PINS Medical Co Ltd; SceneRay Corporation Ltd; NeuroPace Inc; LivaNova PLC; NeuroSigma Inc; Functional Neuromodulation Ltd; Synapse Biomedical Inc; Soterix Medical Inc; FHC Inc; Newronika S.p.A; Renishaw plc; Deep Brain Innovations LLC; BlueWind Medical Ltd; Magstim Company Ltd; Sapiens Steering Brain Stimulation; Bioinduction Ltd; Alpha Omega Engineering
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Deep Brain Stimulation Systems market report include:- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Aleva Neurotherapeutics SA
- Beijing PINS Medical Co Ltd
- SceneRay Corporation Ltd
- NeuroPace Inc
- LivaNova PLC
- NeuroSigma Inc
- Functional Neuromodulation Ltd
- Synapse Biomedical Inc
- Soterix Medical Inc
- FHC Inc
- Newronika S.p.A
- Renishaw plc
- Deep Brain Innovations LLC
- BlueWind Medical Ltd
- Magstim Company Ltd
- Sapiens Steering Brain Stimulation
- Bioinduction Ltd
- Alpha Omega Engineering
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.05 Billion |
| Forecasted Market Value ( USD | $ 4.52 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
